Balance Sheet Breakdown: Immunovant Inc (IMVT)’s Debt-to-Equity and Long-Term Debt/Eq Ratios

Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.

After finishing at $22.40 in the prior trading day, Immunovant Inc (NASDAQ: IMVT) closed at $22.03, down -1.65%. In other words, the price has decreased by -$1.65 from its previous closing price. On the day, 0.98 million shares were traded. IMVT stock price reached its highest trading level at $22.65 during the session, while it also had its lowest trading level at $22.01.

Ratios:

Our goal is to gain a better understanding of IMVT by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.61 and its Current Ratio is at 7.61. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Oppenheimer reiterated its Outperform rating for the stock on October 09, 2024, while the target price for the stock was revised from $47 to $53.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 22 ’25 when Stout Jay S sold 2,195 shares for $23.59 per share. The transaction valued at 51,780 led to the insider holds 139,991 shares of the business.

Geffner Michael sold 2,657 shares of IMVT for $62,679 on Jan 22 ’25. The Chief Medical Officer now owns 132,314 shares after completing the transaction at $23.59 per share. On Jan 15 ’25, another insider, Macias William L., who serves as the Chief Medical Officer of the company, sold 2,383 shares for $23.83 each. As a result, the insider received 56,782 and left with 359,408 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IMVT now has a Market Capitalization of 3741399040 and an Enterprise Value of 2760771584.

Stock Price History:

The Beta on a monthly basis for IMVT is 0.65, which has changed by -0.3847844 over the last 52 weeks, in comparison to a change of 0.25219524 over the same period for the S&P500. Over the past 52 weeks, IMVT has reached a high of $39.55, while it has fallen to a 52-week low of $22.28. The 50-Day Moving Average of the stock is -14.85%, while the 200-Day Moving Average is calculated to be -21.99%.

Shares Statistics:

The stock has traded on average 957.26K shares per day over the past 3-months and 1369710 shares per day over the last 10 days, according to various share statistics. A total of 146.57M shares are outstanding, with a floating share count of 59.16M. Insiders hold about 59.69% of the company’s shares, while institutions hold 53.56% stake in the company. Shares short for IMVT as of 1736899200 were 12832296 with a Short Ratio of 13.41, compared to 1734048000 on 12631893. Therefore, it implies a Short% of Shares Outstanding of 12832296 and a Short% of Float of 14.760000000000002.

Most Popular